Stents Coated With Mammalian Target of Rapamycin Inhibitors (mTOR) Appear to Be the Best Choice in Patients With Antiphospholipid Syndrome and Myocardial Infarction.
作者信息
Mora-Ramírez Mauricio, González-Pacheco Hector, Amezcua-Guerra Luis M
机构信息
Department of Immunology Instituto Nacional de Cardiología Ignacio Chávez, Mexico City Mexico Coronary Care Unit Instituto Nacional de Cardiología Ignacio Chávez, Mexico City Mexico Department of Immunology Instituto Nacional de Cardiología Ignacio Chávez; and Health Care Department Universidad Autónoma Metropolitana-Xochimilco, Mexico City Mexico
出版信息
J Clin Rheumatol. 2016 Aug;22(5):281. doi: 10.1097/RHU.0000000000000409.
PMID:27464778
Abstract
摘要
Zotero 插件